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Abstract
Background: Immediate post-cardiopulmonary bypass (CPB) immune responses and organ injuries in immune-com-
promised patients remain poorly documented.
Method: Sixty-one consecutive patients (30 HIV seropositive and 31 seronegative), undergoing elective cardiac 
valve(s) replacement were enrolled, from a single center hospital, after informed consent was obtained. C-reactive 
protein (CRP) and Erythrocyte sedimentation rate (ESR) were used as biomarkers of  acute inflammatory response.
Results: The mean age was similar between the HIV seropositive and negative group.  Pre-operatively, CRP (p=0.388) 
and ESR (p=0.817) were comparable. The CPB events and durations were significantly different between the two 
groups: duration (p=0.021), clamp aortic duration (p=0.026), bloodtransfusion (p=0.013), total urine output (p=0.035) 
and peak lactate (p=0.040). Post-operatively, there was significant increased biomarkers level in both groups, albeit not 
between the groups with a significant negative correlation between the mean change in CRP levels and mechanical 
ventilation (r=0.548, p=0.002) in the seropositive group (r=0.025, p=0.893). The correlation between pre-operative 
and post-operative difference in CRP and ICU stay was not significant in both groups. A significant drop (p=<0.001) 
in CD4 cells was documented post-operatively in the HIV seropositive group. 
Conclusion: HIV positive patients’ post-operative reactions to cardiac surgery supported by CPB are similar to those 
of  HIV seronegative patients.
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Introduction
In the era of  the Human immunodeficiency virus (HIV) 
pandemic, there have been various concerns about the 
operative risks, infections and benefits of  cardiac surgery 
in patients infected with HIV, as they are known to al-
ready have a compromised immune system, chronic in-
flammation and reduced survival.1,2 This led to cardiac 
surgery departments setting a minimum acceptable CDT 
T-cell count level for HIV positive patients to undergo 
elwctive corrective cardiac surgery, ranging between 250 
and 400 cells/cm3. Acquired immunodeficiency syn-
drome (AIDS) is diagnosed when the CD4 T-cells level 
count drops below 200 cells/cm3 or when opportunistic 
infections arise.3
Following the introduction of  highly active antiretrovi-
ral treatment (HAART), the lifespan of  HIV positive 
patients has increased dramatically. In addition, recent 
research studies suggest that little difference exists with 
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regards to surgical outcomes and duration of  hospital 
stay between HIV positive patients and negative patients 
undergoing cardiac surgery.4
There is very limited information published prospectively 
on the HIV disease profile in correlation with alterations 
and immune system activation during and after cardiac 
surgery supported by CPB. The aim of  the study was 
to investigate the severity of  acute systemic inflamma-
tory response after cardiac surgery in patients infected 
with human immunodeficiency virus in comparison with 
HIV negative patients, using C-reactive protein (CRP) 
and Erythrocyte sedimentation rate (ESR) biomarkers. 
This study also sought to identify pre-operative risk and 
peri-operative complications to determine whether clini-
cal relevant events correlate to alterations of  immune re-




A total of  sixty-one (61) participants were selected as 
participants from a single centre hospital, Inkosi Albert 
Luthuli Central Hospital (IALCH) and were divided into 
two groups i.e. Thirty HIV positive patients and thir-
ty-one HIV negative patients undergoing elective on-
pump cardiac surgery. These HIV positive patients were 
recruited consecutively, and a relatively corresponding 
age-and-gender matched ‘control’ HIV negative patient 
was selected, after informed consent had been sought. 
After noting that no prospective similar study has been 
published, because most studies on HIV patients were 
retrospective studies, case reports and literature reviews, 
a biostatistician was consulted to verify the number of  
participants and data variables required to significantly 
test the hypothesis.
Materials
A Stockert S5 heart - lung machine (CPB) utilizing roller 
pump was used in all patients during data collection. Eu-
rosets Admiral oxygenator and tubing was the only oxy-
genator used during data collection. Admiral oxygenator 
internal surfaces are coated with Phosphorylcoline which 
is the predominant lipid head-group found in the outer 
layer of  cell membranes. Phosphorylcoline has a natural 
affinity for water and binds water tightly around itself, 
as a result does not promote clots formation.  Admiral 
oxygenators require a priming volume of  190 ml, have a 
contact surface area of  1.35 meter square with maximum 
blood flow rate of  7.0 litre/min. Total CPB circuits prim-
ing solution included 1450ml of  Plasmalyte B, 5000i.u of  
heparin and 50ml of  20% Albusol. Standard protocol for 
CPB conduction was not modified; electrolytes and blood 
ph corrections were corrected as per the standard proto-
col to maintain normal ranges. Also, the use of  adrenaline 
and other routine drugs were not prohibited nor limited 
during data collection. 
Mistral cardioplegia delivery sets were used to administer 
cardioprotective solutions which was either cold blood 
cardioplegia delivered at the ratio of  4:1 blood to medsol 
cardioplegic solution at an average delivery pump rate of  
240ml/min for the duration of  four minutes induction 
and 2 minutes maintenance, or ST Thomas II crystalloid 
cardioplegic solution which was delivered at a standard 
protocol of  20ml/kg induction and 10ml/kg mainte-
nance.  Patients’ temperatures were cooled down as per 
the standard unit protocol of  hypothermia which for 
heart valvular surgery range between 28-32 °C, and then 
rewarmed to a minimum core temperatures of  35 °C 
before termination of  CPB. Topical hypothermia which 
employs pouring ice cold normal saline on the heart was 
employed in all patients as a standard protocol during car-
diac surgery.
ADVIA chemistry systems Wide Range C-reactive protein 
(wrcrp) method was used to test for CRP. This method 
measures CRP in serum and plasma by a latex enhanced 
immune-tirbidimetric assay. It is based on the principle 
that the analyte concentration is a function of  the inten-
sity of  scattered light caused by the latex aggregates. The 
latex particles coated with anti-CRP rapidly agglutinate 
in the presence of  C-reactive protein-forming aggregates. 
The wrcrp latex reagent is a suspension of  uniform poly-
styrene latex particles coated with anti-CRP antibody. 
When serum containing CRP is mixed with the latex re-
agent, agglutination takes place resulting in an increase in 
the turbidity. This turbidity is measured at 571 nm. The 
CRP concentration in serum is determined from a cali-
bration curve that is generated with calibrators. 
HIV positive patients were tested for CD4 T-cell count 
using Panleucogating (PLG)/CD4 method which uses 
a sequential gating strategy to identify all CD45+ leuco-
cytes in order to measure the CD4% of  lymphocyte and 
absolute CD4 count. Absolute CD4 counts are derived 
by single platform analyses that incorporate the use of  
Flow-Count beads with a pre-defined concentration.
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Procedure
On the eve of  the operation each participant was identi-
fied, recruited and asked to sign the consent if  they were 
willing to participate in the research study. On the day 
of  the operation upon arrival in operation room, routine 
invasive and non-invasive heamodynamic monitoring 
devices such as peripheral drip line, electrocardiogram 
electrode, pulse oximeter, invasive blood pressure, central 
venous pressure, urine catheter and temperature moni-
toring cable were inserted and/or placed on the patient.
Pre-operative data
Patient demographics such as gender, age, type of  sur-
gery, cardiac ejection fraction, New York Heart Associa-
tion (NYHA) classification and current medication were 
recorded on the data sheet. 
After all monitoring devices were placed on the patients 
just before initiation of  anaesthesia, arterial blood sam-
ples were taken from the radial or femoral invasive arte-
rial catheter. Blood samples were collected for laboratory 
tests using appropriate recommended sample collection 
method and test tubes for each of  the tests i.e. C-reactive 
protein, Erythrocyte sedimentation rate, and CD4 cell 
count (HIV positive patients only). These variable tests 
served as baselines
Intra-operative data
Intra-operative samples included: myocardial protection 
technique employed for each case, blood products trans-
fused, peak-lactate level, total urine output, aortic cross-
clamp duration and CPB duration.
Post-operative data
Post-operative samples included clinical assessments such 
as: duration on mechanical ventilation, duration on pos-
itive inotropic support and duration in the intensive care 
unit, all measured in days. 
On the second post-operative day (48hours) blood sam-
ples were taken by the researcher for post-operative labo-
ratory tests i.e. C-reactive protein, Erythrocyte sedimen-
tation rate and CD4 cell count (HIV positive patients 
only).  These samples were taken according to each test 
standard recommended time that it reach peak levels at, 
and in this study all variables under study are categorized 
as reaching peak after 48 hours of  surgery.  
Patients were followed-up until they were extubated, 
weaned off  inotropes and transferred out of  intensive 
care unit.  
Microsoft excel was used to record variables and relat-
ed demographics for statistical analysis. These were then 
transferred to SPSS version 23 for further analysis.
Ethical considerations: This study was granted ethical 
approval from the Durban University of  technology In-
stitutional Research and Ethics committee (Chairperson: 
Prof  JK Adam, IREC ref  no: REC 96/14, 05/05/2015). 
Results
There was a dominance of  females (54.1%), with 45.9% 
being males. The majority of  participants (36.1%) were 
seen in the 30-40 year age group (Table 1).
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Table 1: Clinical characteristics of the study and control population. 
Variables Study group (HIV 
positive)/n=30 
Control (HIV negative) 
/n=31 
Female 16 (53%) 17 (55%) 
Male 14 (47%) 14 (45%) 
Age (mean ±) 37.8 ± 10.6 37.1 ± 11.9 
Aortic valve Replacement 8 (27%) 4 (13%) 
Mitral valve Replacement 19 (63%) 10 (32%) 
















Ejection fraction  (mean): 48.6% ± 9.4 51.1% ± 11.2 
Type of cardioplegia: 



















Mortality: 1 (3.3%) 1 (3.2%) 
*Clinical Characteristics of the study and control population 
The mean age for the HIV seropositive was 37.8 ± 10.6 
and 37.1 ± 11.9 years for the HIV seronegative group 
with the range being between 18 to 60 years. Types of  
operations comprised of  aortic valve replacement (AVR) 
19.7%, mitral valve replacement (MVR) 32.8% and dou-
ble valve replacement (DVR) 47.5%, which is a combined 
operation for both AVR and MVR. Baseline New York 
heart association (NYHA) of  all patients grading was 
statistically analyzed to determine the frequency for each 
grade. Grade I frequency was four patients (6.6%), grade 
II frequency was thirty-nine patients (63.9%), grade III 
frequency was fourteen (23.0%) and grade IV frequency 
was four (6.6%). The baseline pre-operative ventricular 
ejection fraction (EF) was analyzed and compared be-
tween the two groups, with the mean EF of  48.6% in the 
study group, and 51.1% in the control group. Two types 
of  cardioprotective cardioplegia solution were used in the 
study; with the type of  cardioplegia was to be employed 
being determined by the surgeon. Twenty (32.8%) pa-
tients used Buckberg blood 4:1 cardioplegia and forty-one 
(67.2%) used ST Thomas II crystalloid cardioplegia. Out 
of  thirty patients in the study group, twenty-six (86.7%) 
were on HAART, and four (13.3%) were not on any an-
ti-retroviral treatment. The total study mortality from 
the sixty-one patients was two patients (3.3% mortality). 
Only one patient did not complete the study follow up 
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period, as the patient died three hours after the operation 
(3.3% mortality in the HIV positive group). This patient 
could not be excluded from the data since the cause of  
death may be related to the stratified operative risks under 
study. All other sixty patients completed the follow up 
period, with one other HIV negative patient dying later 
while still in hospital (3.2% mortality in the HIV negative 
group). 
The pre-operative CRP analysis between the study and 
control group showed no significant difference (p=0.388 
and 0.817, respectively) (Figure 1). 
 
Figure 1: Graphical comparison of mean CRP (C-reactive protein) levels pre  
and post-operatively between the two groups 
Post-operatively CRP mean was slightly higher in the 
study group (212.59 ± 23.731), as compared to the con-
trol group (190.68 ± 57.919), however statistical analy-
sis showed that the difference in results was not signif-
icant (p=0.115). Similarly, the mean ESR between the 
study group (43.07 ± 23.067) and control group (49.68 ± 
19.139) showed no significant difference (p=0.214) (Fig-
ure 2). 
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Figure 2: Graphical representation of mean ESR levels pre and post-operatively  
between the two groups 
To determine if  there were predisposing factors (viral 
load, CD4 count and anti-retroviral medication) that 
could increase risks of  cardiac surgery supported by CPB 
in HIV positive patients, patients infected with HIV were 
investigated to evaluate the changes in these parame-
ters (Table 2). The pre-operative CD4 cells levels were 
compared with levels at three days post-operative. Paired 
sample statistical results showed pre-operative CD4 cells 
mean of  598.76 ± 205.576 and the post-operative CD4 
cells mean was 405.97 ± 119.089.
Table 2: Correlation of predisposing factors and ICU stay 
Parameters r - value p- value 
CD4 cell diff vs. CPB duration .258 .177 
CD4 cell diff vs. Age .064 .741 
CD4 cell diff vs. NYHA grading .056 .775 
CD4 cell diff vs. ICU stay .248 .195 
 
As anticipated, there was a decrease in CD4 cells post-
operatively, and this difference was strongly significant 
(p= <0.001) when compared to pre-operative levels. The 
difference between preoperative and postoperative CD4 
cells levels was further analyzed and correlated with surgi-
cal outcome determinant variables such as CPB duration, 
age, NYHA grading and ICU stay to investigate whether 
or not CD4 cells level is a predictive factor for surgical 
outcome in HIV positive patients.
There was no significant correlation between change in 
CD4 cells and CPB duration, age, NYHA grading and 
ICU stay (p=0.177, 0.741, 0.775 and 0.195 respectively). 
In this study only the highly active anti-retroviral treat-
ment proved to be a predictive factor for CD4 cells lev-
el changes after cardiac surgery in these immune-com-
promised patients (Figure 3). The group of  patients on 
HAART had the CD4 cells difference mean of  177.7600 
± 151.36, as compared to the mean of  286.7500 ± 264.76 
in patients who were not taking anti-retroviral treatment.
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Figure 3: Difference in CD4 cells between patients on HAART and those who are not 
Discussion
Cardiac surgery and cardiopulmonary bypass (CPB) ini-
tiates a systemic inflammatory response, resulting in a 
whole-body inflammatory reaction.5  The extent of  this 
inflammatory reaction will vary from patient to patient, 
with persistence of  any degree of  inflammation  con-
sidered potentially harmful to the cardiac patient.6 , and 
may further be exacerbated in patients infected with HIV 
leading to increased morbidity and mortality.7 In the era 
of  the HIV pandemic, studies have earlier reported poor 
outcomes of  cardiac surgery in HIV seropositive popu-
lation.8,9 As a result cardiac surgery in HIV seropositive 
patients was performed with caution and forbidden in pa-
tients with AIDS, due to fear of  post-operative risks of  
infection.2,10
With the introduction of  highly active antiretroviral treat-
ment (HAART), studies thereafter have reported excel-
lent surgical outcomes in HIV seropositive patients.11 As 
the number of  HIV positive patients requiring open heart 
surgery increases, and is expected to increase further as the 
incidence increases, it becomes imperative to understand 
the effect of  cardiac surgery with CPB in HIV positive 
subjects. Furthermore, there is a paucity of  data related 
to the South African context, which our study has been 
tempted to address. To the knowledge of  the authors this 
makes this study the first and largest prospective study to 
be ever conducted in HIV positive patients undergoing 
cardiac surgery supported by CPB in South Africa.
Our study reports no post-operative complications, as 
well as a very low overall mortality, as out of  sixty-one 
patients, only two patients (3.3%) demised (one patient in 
each group). In both demised patients, pre-operative and 
post-operative variables were within the same ranges as 
other patients, and there was no variable or biomarkers 
that were profoundly high when compared to the remain-
ing patients to associate with a possible predictive cause 
of  death.
 
Our study also reports an absence of  post-operative, 
acute renal failure requiring dialysis, neurological com-
plications and sepsis in both groups, including HIV se-
ropositive patients who were not on HAART treatment 
even though they are at high risk to infections.12 We also 
found that differences in pre-operative and post-operative 
CRP levels correlated strongly with duration of  mechan-
ical ventilation in the study group. The C-reactive protein 
(CRP), being a reliable indicator for the acute systemic 
inflammatory response, has become a necessity in the 
monitoring and management of  cardiac patient during 
the preoperative and post-operative periods.13-14 Elevated 
preoperative CRP levels as minimal as 5mg/L have been 
found to be independent risk factors associated with in-
creased risk of  complications and post-operative infec-
tions.15 A pre-operative mean CRP of  13.48mg/L in the 
HIV positive group, and 13.16mg/L in the HIV negative 
group were found in our study, but were not associated 
with complications or adverse outcomes post-operatively. 
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In addition, we did not show the pattern of  HIV positive 
individuals having significantly high levels of  CRP as re-
ported by Bryan et al16.
The post-operative inflammatory responses have been 
found to influence the development of  multiple organ 
failure including myocardial dysfunction, respiratory 
failure and renal dysfunction.17 In our study, as expect-
ed, CRP levels increased significantly post-operatively in 
both HIV positive and negative groups, but were similar. 
However, significant differences were observed between 
the two groups when CRP levels were correlated with 
postoperative clinical outcomes.   A strong negative cor-
relation between the CRP levels and post-operative me-
chanical ventilation duration in the HIV positive group 
was observed, in keeping with the results from Taher et 
al,18 but was not observed in the HIV negative group.  
Khaled et al19 reported that elevated CRP levels post-op-
eratively are associated with a prolonged stay in the inten-
sive care unit (ICU) and that a post-operative CRP level 
of  about 51mg/L correlated significantly with the ICU 
length stay (p=0.04) duration up to 7 days.19 In our study, 
this was not observed even though post-operative CRP 
was much higher than 51mg/L in both groups. In addi-
tion, none of  our patients required re-admission to ICU 
or re-intubation for mechanical ventilation after ICU dis-
charge. Our findings may be substantiated by those from 
Sophie et al and Mara et al, who found that post-oper-
ative CRP levels at the time of  patients discharge from 
ICU did not necessarily indicate any clinical post-ICU 
adverse outcomes.20-21
Further analysis between CRP levels, NYHA class and 
age was non-significant, and in keeping with the litera-
ture.22,23 This was also observed with the ESR, which is 
an additional inflammatory biomarker with CRP in rheu-
matic fever and rheumatic heart disease24. These findings 
may be attributed to the influence of  anaemia and poly-
cythaemia, rendering it more frequently abnormal, and 
therefore less reliable.25  
To further determine other possible predisposing fac-
tors for observed increased post-operative CRP levels, 
the difference between pre-operative and post-operative 
CPR levels in both groups were correlated to pre-opera-
tive and CPB variables. The findings in the HIV positive 
group are in contrast to current literature which supports 
a positive correlation between CRP and NYHA class.25 
The duration of  acute systemic inflammatory response 
(SIR) and mechanisms that lead to the lengthening of  
acute SIR in patients that have been operated on under 
cardiopulmonary bypass have been explored.26 During 
bypass, blood transfusions induce a second insult to the 
systemic inflammatory response that already exists after 
cardiac surgery, leading to an exacerbation of  the SIR.27 
In addition, this adverse effect of  transfusion, which in-
cludes immune response reactions leading to activation 
of  the inflammatory milieu, may be more pronounced 
in HIV-infected patients, and may explain the correlation 
between CRP levels and CPB time28, also observed in our 
HIV positive patients.
Other variables like the urine output of  0.5ml/kg/hr are 
predictive of  renal failure post CPB, and it has been found 
to be a lethal complication associated with multi-organ 
failure.29 Although our study indeed observed a negative 
correlation between post-operative CRP and total CBP 
urine output in both groups, these were not statistically 
significant.
Hyperlactatemia is common after cardiac surgery and 
studies have found that a lactate threshold of  about 3 
mmol/L at ICU admission is able to identify a population 
at risk of  morbidity and mortality after cardiac surgery.30 
Although these levels were also seen in our study, it was 
not associated with accompanying post-surgical com-
plications. Imhof  et al31 reported hyperlactemia in HIV 
positive patients, and found that it is strongly associated 
with anti-retroviral medication; however in our , study 
pre-operative baseline lactate was not measured.31 In our 
study we showed a strong significant correlation between 
postoperative CRP and the lactate level during CPB  in 
the study group (HIV+), and notes the lack of  published 
literature in this area of  research.
It has been shown that CD4 cells levels determine the 
progression of  HIV in infected individuals.32 In our study 
the post-operative CD4 cells count was significantly low-
er, and mirrors those reported by Alejandro, et al.2 Fur-
ther analysis on HIV positive patients taking HAART 
versus those who were not on therapy, showed that the 
CPB duration was significantly longer in those subjects 
who were not on HAART therapy. The lack of  strong 
correlations between mean CD4 cells and variables like 
age, baseline NYHA grading and CPB duration suggest 
that even though there is a significant change in CD4 cells 
level post-operatively, these changes are not influenced 
by patient pre-operative variables and CPB duration. The 
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weak positive correlation observed between mean CD4 
cells difference are similar to those of  Cacala, et al who 
reported that CD4 counts had no relation with in-hospital 
outcome in HIV-positive surgical patients.33 Unfortunate-
ly, we were not able to establish whether or not HAART 
is associated with improved outcomes following cardiac 
surgery with CPB in HIV positive patients, due to a short 
post-operative follow up period.
 
Conclusion
This investigation shows that the acute systemic inflam-
matory response in HIV positive patients is similar to that 
of  HIV negative patients, with similar patterns of  CRP 
levels and ESR level. To our knowledge this is the first 
study to be conducted prospectively in South Africa and 
we indeed bridged the gap between the clinical outcomes 
observed retrospectively by Blyth et al.34 We confirmed 
that laboratory biomarkers are significantly increased af-
ter cardiac surgery with CPB; however they do not seem 
to indicate any short-term complications or poor surgical 
outcomes. Furthermore this study has shown that car-
diac surgery may be safely performed even in subjects 
who are not on HAART therapy with no post-operative 
complications compared to those on HAART. Although 
we found a significant drop in CD4 cells post-operatively 
in HIV positive patients this did not seem to affect the 
short-term surgical outcomes.
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